Clemex Discloses First Quarter Results
21 9월 2013 - 3:19AM
Access Wire
Montreal, QC - September 20th,
2013-- Clemex Technologies Inc.
(TSXV: CXG.A), designer
and manufacturer of Image Analysis systems and software for
microscopy applications, announces its financial results for the
first Quarter of FY2014 ending July 31st, 2013. Sales reached $1,042,744
compared to $1,305,152 for the same period last year. The
Corporation ends this quarter with a Net Loss of $267,375, and a
net loss of $256,567 attributable to Clemex Technologies compared
to a net loss of $44,265 posted last year.
During this third
Quarter, the Corporation made several sales to major clients in the
manufacturing sector in North America: Swagelok OH and Sauer
Danfost, SC. A few sales were made at international to Nitrex,
Mexico and China. As far as Canada, the Corporation made an
important sale in the pharmaceutical sector to Impopharma, ON and
several microscopes sales to Quebec Universities and
Colleges.
FINANCIAL HIGHLIGHTS
First
Quarter
-----------------------------------------------------
| Fiscal | | | | |
|Years | | | | |
| | | | | |
| | 2014 | 2013 | | |
|---------------------------------------------------|
| | | | | |
| | $ |$ | | |
| | | | | |
| | | | | |
| | | | | |
|---------------------------------------------------|
|Sales |1 ,042,744 |1,305,152| | |
|---------------------------------------------------|
| | | | | |
|---------------------------------------------------|
|Gross Margin |522 ,649 |664 ,866 | | |
|---------------------------------------------------|
|Gross Margin % |5 0,1% |50 ,9% | | |
|---------------------------------------------------|
|Total Operating Expenses|787 ,674 |683 ,631 | | |
|---------------------------------------------------|
| | | | | |
|---------------------------------------------------|
|Income Taxes |2 ,350 |25 ,500 | | |
|---------------------------------------------------|
| Net Result | (267,375)|(44,265) | | |
|---------------------------------------------------|
| Net Result |(256,567) |(44,265) | | |
|attributable to Clemex | | | | |
|Technologies Inc. | | | | |
|---------------------------------------------------|
| | | | | |
|---------------------------------------------------|
|Global Result per share|(0.008) |(0.001) | | |
-----------------------------------------------------
(basic and diluted)
Clement Forget,
President and CEO of Clemex Technologies Inc.
declared: "We are of course quite disappointed whit these First
Quarter results. Traditionally Q1 is never the best Quarter for the
Corporation, but this one in particular has been heavily affected
by the report of several sales in time, mainly in the USA. We have
mentioned several times in the past that the manufacturing sector
in the USA is still not running at full capacity, and this is
hurting Clemex business which relies heavily on that
sector.
On the positive side,
our orders pipeline for Q2 shows that several orders were indeed
postponed further in time."
Despite this short
term slowdown in our traditional business, we maintain our
marketing and R&D efforts in the Hematology sector.
Consequently, despite the fact that this sector does not generate
any income yet, it requires substantial investment of money efforts
which reflects on the overall profitability of the
Corporation.
Concerning the
hematology instrument project, Mr. Forget continued;
"Our two instruments already in place in specialized
laboratories work well and in accordance with their specifications.
Thus everything looks good for the validation process which should
begin very soon. The validation process is a necessary step in view
of Health Canada and the FDA certification, which is mandatory
prior to the commercialization of the instrument in Hospitals. We
estimate that we could be able to offer the same
instruments to hospitals sometime early 2014. We are
however ready to market the instrument for various Veterinary
applications, where no FDA certification is required, and we are
already working with an important group of veterinary laboratories
in the US.
About Clemex Technologies, Inc.
Clemex Technologies
Inc. develops, manufactures and markets image analysis systems and
software used by quality control and research microscopy
laboratories. Clemex' customer base spans over many countries in
America, Europe, Asia and encompasses major Research and
Development Centers, prestigious Universities and large
manufacturing industries in various fields including healthcare,
automotive, aerospace, raw materials manufacturing,
pharmaceuticals, mining and other sectors.
--30--
Clemex Technologies Inc,
800 Guimond,
Longueuil, QC, Canada J4G 1T5,
Contact:
Clement
Forget,
President and CEO
Tel: 450.651.6573
Email:
ir@clemex.com
Clemex Technologies Inc. (TSXV:CXG.A)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Clemex Technologies Inc. (TSXV:CXG.A)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024